Table 4 Changes in CGI-S Scale during treatment
From: Xenon in the treatment of panic disorder: an open label study
Group | ||||||
|---|---|---|---|---|---|---|
“Pure ”PD (n = 42) | “Comorbid” PD (n = 39) | Total (n = 81) | ||||
n | % | n | % | n | % | |
CGI-S, V1 | ||||||
Moderately expressed disease | 4 | 10.3 | 1 | 2.4 | 5 | 6.2 |
Significantly expressed disease | 34 | 87.2 | 38 | 90.5 | 72 | 88.9 |
Serious disease | 1 | 2.6 | 3 | 7.1 | 4 | 4.9 |
Total | 39 | 100.0 | 42 | 100.0 | 81 | 100.0 |
CGI-S, V2 | ||||||
Moderately expressed disease | 19 | 48.7 | 1 | 2.4 | 20 | 24.7 |
Significantly expressed disease | 20 | 51.3 | 39 | 92.9 | 59 | 72.8 |
Serious disease | 0 | .0 | 2 | 4.8 | 2 | 2.5 |
Total | 39 | 100.0 | 42 | 100.0 | 81 | 100.0 |
CGI-S, V3 | ||||||
Moderately expressed disease | 19 | 48.7 | 5 | 11.9 | 24 | 29.6 |
Significantly expressed disease | 20 | 51.3 | 37 | 88.1 | 57 | 70.4 |
Total | 39 | 100.0 | 42 | 100.0 | 81 | 100.0 |
CGI-S, V4 | ||||||
Weakly expressed disease | 0 | .0 | 20 | 47.6 | 20 | 24.7 |
Moderately expressed disease | 20 | 51.3 | 22 | 52.4 | 42 | 51.9 |
Significantly expressed disease | 19 | 48.7 | 0 | .0 | 19 | 23.5 |
Total | 39 | 100.0 | 42 | 100.0 | 81 | 100.0 |
CGI-S, V5 | ||||||
Borderline state | 0 | .0 | 6 | 14.3 | 6 | 7.4 |
Weakly expressed disease | 1 | 2.6 | 36 | 85.7 | 37 | 45.7 |
Moderately expressed disease | 37 | 94.9 | 0 | .0 | 37 | 45.7 |
Significantly expressed disease | 1 | 2.6 | 0 | .0 | 1 | 1.2 |
Total | 39 | 100.0 | 42 | 100.0 | 81 | 100.0 |
CGI-S, V6 | ||||||
Normal state | 0 | .0 | 5 | 11.9 | 5 | 6.2 |
Borderline state | 32 | 82.1 | 37 | 88.1 | 69 | 85.2 |
Weakly expressed disease | 7 | 17.9 | 0 | .0 | 7 | 8.6 |
Total | 39 | 100.0 | 42 | 100.0 | 81 | 100.0 |